RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
VAFNX
Price
$31.27
Change
-$0.42 (-1.33%)
Updated
Jun 13 closing price
Net Assets
16.35B
Interact to see
Advertisement

RGEBX vs VAFNX

Header iconRGEBX vs VAFNX Comparison
Open Charts RGEBX vs VAFNXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
Invesco American Franchise R5
Price$31.27
Change-$0.42 (-1.33%)
VolumeN/A
Net Assets16.35B
RGEBX vs VAFNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGEBX vs. VAFNX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and VAFNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. VAFNX (16.4B). RGEBX (0.00) and VAFNX (0.00) have matching dividends . RGEBX was incepted earlier than VAFNX: RGEBX (11 years) vs VAFNX (14 years). RGEBX (1.09) is less costly to investors than VAFNX (0.70). VAFNX is a more actively managed with annual turnover of: 51.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than VAFNX: RGEBX (250) vs VAFNX (1000000). VAFNX annual gain was more profitable for investors over the last year : 8.13 vs. RGEBX (7.68). RGEBX return over 5 years is better than : 45.42 vs. VAFNX (28.26).
RGEBXVAFNXRGEBX / VAFNX
Total Expense Ratio1.090.70156%
Annual Report Gross Expense Ratio1.090.70156%
Fund Existence11 years14 years-
Gain YTD4.829-0.351-1,378%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets306B16.4B1,866%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.688.1394%
Returns for 3 years51.0165.1078%
Returns for 5 years45.4228.26161%
Returns for 10 years65.8778.8983%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd